SPARK Impact Investor

SPARK Impact build world-class businesses that offer best investment return. SPARK Impact Limited is authorised and regulated in the UK by the Financial Conduct Authority. SPARK Impact Limited currently manages the Northwest Fund for Biomedical.
SPARK Impact Limited is working in partnership with the Isle of Man EDS to attract new business to the Isle of Man and to grow existing businesses.
Technology: Researching Mechanisms of Disease
Industry: Preventive Medicine
Headquarters: Liverpool, England
Founded Date: 2011
Employees Number: 1-10
Funding Status: N/A
Investor Type: N/A
Investment Stage: N/A
Number Of Exits: N/A

Visit Website
Register and Claim Ownership